DBV Technologies | DBVT - Credores Comerciais





Credores Comerciais Alterar Data
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Amarin USD 40.43M 21.63M 2026-09
BioCryst Pharmaceuticals USD 14.58M 3.12M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
DBV Technologies USD 13.8M 25.7M 2026-09
Galectin Therapeutics USD 3.7M 99K 2024-06
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
Incyte USD 235.37M 1.16B 2026-09
Insmed USD 84.3M 9.75M 2026-09
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
PTC Therapeutics USD 41.59M 1.14M 2026-09
Sarepta Therapeutics USD 45.7M 5.28M 2026-09
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
United Therapeutics USD 520.2M 22.4M 2026-09